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The long-term prognosis of adult patients with patent
ductus arteriosus treated medically or surgically has not
been demonstrated. One hundred seventeen adult pa-
tients ranging in age from 18 to 81 years (mean 36) were
followed up for 1 to 37 years (mean 18). Forty-five pa-
tients were treated nonsurgically and 72 had surgical
closure. The nonsurgical group experienced significantly
more cyanosis (p =0.002) and had fewer diastolic mur-
murs (p > 0.001) than did the surgical group. In the
nonsurgical group, patients with cardiomegaly before
treatment were more likely to die (p > 0.001) than were
patients who did not have cardiomegaly.
In the surgical group, patients with cardiomegaly be-
Patent ductus arteriosus is a rare entity in adults that may
result in irreversible pulmonary hypertension, congestive
heart failure and premature death. There are few studies
relating surgical and nonsurgical treatment to long-term
prognosis in adults with patent ductus arteriosus. In this
report we describe our experience with isolated patent ductus
arteriosus (with or without pulmonary hypertension) in the
adult.
Methods
Study patients. From 1951 to 1984, there were 117
patients seen at the Cleveland Clinic with a diagnosis of
isolated patent ductus arteriosus, with or without pulmonary
hypertension. There were 95 women and 22 men in our
study group. We have achieved follow-up for 114 (97%)
of these 117 patients. The patients were classified into two
groups: those who received nonsurgical therapy (no treat-
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fore treatment had a worse prognosis (p = 0.09) than
that of patients with normal heart size. Seven patients,
five in the nonsurgical and two in the surgical group,
presented with a pulmonary artery systolic pressure
greater than 100 mm Hg. Five of these patients are alive
and well at a mean follow-up time of 18 years. The two
nonsurvivors were in the nonsurgical group and died at
4 and 19 years of follow-up, respectively. Adult patients
with patent ductus arteriosus should be treated sur-
gically, especially if cardiomegaly is seen at initial pre-
sentation.
(J Am Coll Cardiol 1986;8:280-4)
ment or medical therapy) and those who received surgical
therapy.
Thirty-three patients received no therapy and 12 received
medical therapy alone. Sixty-eight patients (58%) under-
went surgical closure of the patent ductus arteriosus. Four
patients had combined medical and surgical therapy and
were considered as surgical patients. When all patients were
considered at initial diagnosis, 57 were in New York Heart
Association functional class I, 51 in class II, 7 in class III
and 2 in class IV. There was no statistically significant
difference between the surgical and nonsurgical groups based
on their admission functional class.
Clinical presentation. Symptoms at diagnosis were
comparable in the two groups (Table 1). Thirty-seven (32%)
of the total 117 patients presented with exercise intolerance.
This was the most common symptom at presentation. Twenty-
nine percent of the patients complained of dyspnea. Cy-
anosis at initial presentation was more frequent in the non-
surgical group (p = 0.001). Nine patients in this group
compared with no patients in the surgical group were cy-
anotic on admission (p = 0.002). Thirty-seven patients
(32%) were asymptomatic at the time of initial presentation.
Ninety-seven percent of the patients (114 of 117) pre-
sented with a systolic murmur, generally of grade 2 to 4/6
in intensity. It was heard best at the left upper sternal border
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in most patients. The intensity of the murmur was com-
parable in the surgicaland nonsurgicalgroups. A continuous
murmur was heard in 61% of the 117patients. Four patients
presented with no heart murmur. Only 38% of the nonsur-
gical patients demonstrated a diastolic murmur, whereas
71% of the surgical patients had a diastolic murmur ranging
in intensityfrom grade 2 to 5/6 (p > 0.001). The pulmonary
componentof the second heart sound was heard with equal
intensity in the nonsurgical and surgical groups. The fre-
quency of a systolic thrill or third heart sound was not
significantly different in the two groups.
The electrocardiogram revealed normal sinus rhythm in
95% of patients. In the nonsurgical group 13 patients dem-
onstrated right ventricular hypertrophy and 5 patients dem-
onstrated left ventricularhypertrophy on electrocardiogram.
In the surgical group, 10 patients had evidence of right
ventricularhypertrophy and 13 patients had evidenceof left
ventricular hypertrophy.
There was no difference between the surgical and non-
surgicalgroups based on the type or amount of medications
takenat their initialpresentation.Eighty-ninepatients(76%)
were taking no medication. Infective endocarditis was seen
in 3 of the 117 patients preoperatively.
A total of 16 patients (14%) demonstrated calcification
of the ductus either on chest X-ray film or at surgery. In
the surgicalgroup, 11 patientshad ductus calcification; their
age ranged from 28 to 70 years (mean 48.5). In the non-
surgical group, five patients had calcification; their mean
age was somewhat greater (61 years).
Nonsurgical group. There were 45 patients in the non-
surgical group (34 women and 11 men). The age at initial
presentation ranged from 20 to 81 years (mean 43). Car-
diomegaly was found in 45% of patients in this group at
the time of initial presentation. Sixteen patients (36%) dem-
onstrated increased pulmonary vascularity on the initial chest
X-ray film.
The pulmonary artery pressure was measured at cardiac
catheterization in 17 of the 45 patients; the mean systolic
anddiastolicpressureswere66 and 37 mm Hg, respectively.
A wide range of pulmonary artery pressure was seen. The
mean cardiac index was 3.7 liters/min per m2 and the mean
Table 1. Symptoms at Presentation in 117 Patients
Table 2. Cause of Death in 22 of 114 Patients at Follow-Up
pulmonary to systolic flow ratio (Qp/Qs) measured in seven
patients was 1.7.
Nonsurgical follow-up. The length of follow-up of our
45 nonsurgical patientswas 1to 37 years (mean 15).Follow-
up evaluation was obtained in 44 (98%) of the 45 patients.
The age at follow-upranged from 28 to 92 years (mean 57).
Thirty-eight percent who were followed up (17 patients) of
the 44 patients in the nonsurgical group had died at follow-
up (Table 2). Six patients died of congestive heart failure,
four of myocardial infarctionand four of noncardiacdisease.
Fifteen patients (34%) were asymptomatic at the time of
follow-up. They comprise 56% of the 27 patients who have
survived. Eight patients complained of shortness of breath,
one had congestive heart failure, one complained of angina
pectoris, one required treatment for hypertension, one had
a cerebrovascular accidentand only one patientwas disabled
because of congestive heart failure.
At follow-up, 16(59%)of the 27 survivingnonsurgically
treated patients were in functional class I, 8 (30%) were in
class II and 3 (11 %) were in class III; no patient was in
class IV. Twenty-one (78%) of the 27 patients remained in
stable condition, whereas 5 (19%) were in improved con-
dition and 1 was in poorer condition.
There was one intraoperative death, which involved a 29
year old woman with severe pulmonary hypertension and
right ventricular dysfunction, who died during anesthesia
induction for correction of the patent ductus arteriosus and
was considered as a nonsurgical patient.
Surgical group. There were 72 patients in the surgically
treated group consisting of 61 women and 11 men whose
mean age at presentation was 32 years (range 18 to 68).
Cardiomegaly was seen in 34 (47%) of the patients. Twenty
patients demonstrated increased pulmonary vascularity on
the initial chest X-ray evaluation.
Thirty-seven patients (51 %) were in functional class I at
the time they were first seen at the Cleveland Clinic, 32
(44%) were in class II and only 3 (4%) were in class III.
There were no patients in functional class IV at the time of
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initial presentation . Fifty-eight patients (81%) were taking
no medication at initial presentation.
Cardiac catheterization was performed in 37 of the 72
patients . The mean pulmonary artery systolic pressure was
36 mm Hg (range IS to 118). The mean cardiac index was
3.5 liters /min per m2 for the 20 patients for whom a cal-
culation was obtained . The mean Qp/Qs ratio was 1.9: I in
the 19 patients in whom it was measured .
The size of the ductus varied widely . The largest ductal
diameter was 2.5 ern . One patient demonstrated aneurysmal
dilat ion . All patients underwent ductal division and ligature ,
except for two patients with a calcified ductus who required
cardiopulmonary bypass.
Surgical follow-up. The follow-up period in 70 patients
(97%) ranged from I to 30 years (mean 19). The patients'
age at follow-up ranged from 25 to 77 years (mean 51).
Two patients were lost to follow-up . Of the 70 patients
followed up , 65 (93%) were alive at follow-up and 5 had
died (Table 2). Two patients died of myocardial infarction
and one died of congestive heart failure unrelated to the
ductus arteriosus. The cause of death was noncardiac in one
patient and unknown in one. In none of these five patient s
was death related to preoperative or postoperative pulmo-
nary hypertension. Fifty-two (80%) of the surviving surgical
patients were asymptomatic. Rare episodes of angina , short-
ness of breath and easy fatigability were elicited . No patient
was disabled because of cardiovascular compromise at fol-
lOW-Up. Eighty percent (52 of 65) were in functional class
I at follow -up and 60% of the patients had clinical improve-
ment after surgical treatment. In only one patient did the
clinical course deteriorate from clas s I to class II at 13 years
of follow-up (this patient had pulmonary hypertension).
Crossover group. Three patients originally treated med-
ically later underwent surgical closure of the patent ductus
arteriosus and are considered in the nonsurgical group. Two
of the three were in functional class I at presentation and
at 10 and 12 years of follow-up, respectively . Surgical clo-
sure was performed electively at the patients' request. The
third patient was in class I at presentation and required
surgical closure 3 years later for congestive heart failure .
This patient had an uneventful hospital course and is doing
well I year later.
Pulmonary hypertension. Seven patients, five in the
nonsurgical and two in the surgical group, with pulmonary
artery peak systolic pressure above 100 mm Hg at the time
of initial presentation had long-term follow-up. In the five
nonsurgical patients a high pulmonary artery pressure may
have been the reason they were not treated surgically. Pul-
monary vascular resistance and pulmonary arteriolar resist -
ance were not calculated in these five patients . One patient
died of right heart failure 4 years after diagnosis. A second
patient died of congestive heart failure after 16 years of
follow-up; before that time, she was in functional class II.
Two patients are currently in class II at 19 and 26 years of
follow-up , respectively. Finally, a 20 year old man with a
pulmonary artery pressure of 128173 mm Hg was found to
be in functional class I at 19 years of follow-up . This patient
also demonstrated a bidirectional shunt at the time of his
initial cardiac catheterization .
One of the two patients who were operated on with a
pulmonary artery systolic pressure greater than 100 mm Hg
is in functional class I at 8 years of follow-up. At the time
of surgery, he was found to have a very short but very wide
patent ductus . The second patient, a 45 year old man with
a pulmonary artery pressure of 104/55 mm Hg, is currently
in functional class II with mild congestive heart failure. At
the time of surgery he had a very wide ductus measuring
2.5 em. In neither of these two patients were shunt flows
available at initial study . Thus, five of our seven patients
with a peak pulmonary artery systolic pressure greater than
100 mm Hg are alive at a mean of 17 years of follow-up.
Survival. Long-term follow-up was obtained in 114 of
117 patients with isolated patent ductus arteriosus. The 10
year survival rate for all patients (surgical and nonsurgical)
was 90%; of those patients followed up for 25 years , the
overall survival was 78%. The group treated nonsurgically
consisted of 45 patients who received either no treatment
(33 patients) or medical therapy alone (12 patients). Patients
who were treated surgically had a significantly better sur-
vival rate than those patients treated nonsurgically (p =
0.003) (Fig. I). The pretreatment functional class was not
predictive of the degree of clinical impairment after treat -
ment for either the nonsurgical (p = 0.09) or the surgical
(p = 0.75) patients . Table 3 compares the clinical condition
after treatment in the nonsurgical and surgical groups . Fig-
ure 2 illustrates the significant difference in long-term prog-
nosis based on the presence of pretreatment cardiomegaly
for the two groups.
Surgically treated patients had improved morbidity and
mortality rates. At a mean follow-up of 19 years, 60% of
the surgically treated patients reported improvement com -
pared with only 19% of the patients treated nonsurgically .
Because of the small number of patients who underwent
cardiac catheterization during this time, our hemodynamic
data were not helpful in predicting functional class after
treatment.
Discussion
Patients with isolated patent ductus arteriosus who re-
ceive medical therapy or no treatment have a decreased long-
term life expectancy rate 0-3). Campbell (3) found that
34% of patients died by age 40 , and 61% died by age 60 .
Other report s (4) have shown conflicting results. In our long-
term follow-up of 114 patients , mortality was 17% in the
nonsurgical group and only 7% in the surgical group.
Clinical presentation. Our data on clinical presentation
are in agreement with those of several previous reports (5-9) .
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Table 3. Clinical Condition of 90 Patients at
Last Follow-Up
Figure 1. The statistically significant difference in survival be-
tween 45 patients (nonsurgical) who received either no treatment
or medicaltherapyand 72 patients who receivedsurgical treatment
(p = 0.(03).
Most patients were women and often asymptomatic. Only
61% of our patients presented with a continuous murmur.
The nonsurgical group experienced significantly more cy-
anosis than did the surgical group (9 versus 0%) (p =
0.001). We believe that this represents increased pulmonary
vascular resistance with right to left shunting in the non-
surgical group; however, because many of our patients were
diagnosed before measurement of pulmonary artery pressure
was routinely performed, this could not be verified by our
cardiac catheterization data. The nonsurgical group had a
lesser incidence of diastolic murmurs than did the surgical
group (p > 0.001), possibly as a result of increased pul-
monary artery systolic pressure.
The complications of patent ductus arteriosus are well
known (1-3,5,6,10-12). Eisenmenger's syndrome, conges-
tive heart failure, infective arteritis and calcification of the
ductus may occur. Kelly (5) reported that calcific deposits
in the ductus arteriosus were common after age 30. In our
adult series the incidence was 14%. Of the 11 patients who
demonstrated calcification of the ductus at the time of sur-
gery, only 2 required cardiopulmonary bypass and all re-
sponded to conventional surgical closure. There were no
complications in our patients with calcified or aneurysmal
patent ductus arteriosus.
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Surgical indications and results. The timing of surgical
correction is controversial. Nadas and Fyler (13) recom-
mended that an asymptomatic child with a patent ductus
arteriosus and normal heart size on chest X-ray film be
treated medically. Black and Goldman (6) recommended
that surgical ductus closure is indicated for asymptomatic
children and young adults, symptomatic infants with in-
tractable congestive heart failure and adults with pulmonary
hypertension. In contrast, Marquis et al. (7) recommended
surgery in the older patient at diagnosis. They found that
significant clinical deterioration with an increase in heart
size could be prevented by surgery, and that left ventricular
impairment was a major surgical risk even in patients with
a small patent ductus arteriosus. In the adult patient, surgical
risk may be increased by pulmonary hypertension, aneurysm
of the ductus with or without calcification and chronic en-
docarditis resulting in friable tissues (14). John et al. (15)
followed up 131 patients with patent ductus arteriosus (mean
age 22 years) for 1 to 11 years; 81% of the 62 patients who
YEARS
Figure 2. The cumulative survival for both the surgical (A) and
nonsurgical (B) treatment groups based on pretreatment cardio-
megaly. Those patients who present with an increased heart size
appear to have a decreased life expectancy.
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had hemodynamic evaluation had some elevation of pul-
monary artery pressure. Division and suture of the ductus
with aortic cross clamping under normothermic conditions
was performed in 61 of their patients. They found excellent
long-term survival in their surgically treated patients. Five
early deaths occurred in those patients with severe pul-
monary hypertension (pressures of 70 to 150 mm Hg), but
there were no deaths in patients with pressures less than
70 mm Hg.
We have found that patients can tolerate a very high
pulmonary artery pressure for long periods without deteri-
oration of their clinical status. Elevation of the pulmonary
arteriolar resistance may indicate a subset of patients at high
risk despite surgical treatment. Our study is in agreement
with previous studies demonstrating calcification and aneu-
rysmal dilation of the patent ductus arteriosus in the older
population. Infective endarteritis is a rare complication and
was observed in only three of our patients preoperatively.
The endocarditis usually occurs on the pulmonary side of
the ductus. One of our patients developed endocarditis of
the calcified mitral anulus 12 years after complete closure
of a patent ductus.
Conclusions. In a long term follow-up of 114 of 117
adult patients evaluated between 1951 and 1984, we found
that patients who present with cardiomegaly who are treated
nonsurgically have a much worse prognosis than do those
who are treated surgically. Twelve of 20 nonsurgical pa-
tients with cardiomegaly died compared with 5 of 34 surgical
patients. The higher frequency of patients with cyanosis in
the nonsurgically treated group suggests that elevation of
pulmonary arteriolar pressures at the time of initial presen-
tation may be a prognostic indicator of decreased long-term
survival. An increased left to right shunt, as suggested in
the surgical group by an increased frequency of diastolic
murmurs, may also be an indication for surgical interven-
tion. The functional class at presentation was not predictive
of long-term survival in our patient group. Elevation of
pulmonary arteriolar pressure (without apparent Eisenmen-
ger's physiology) and enlargement of the cardiac silhouette
are indications for early surgical intervention. We recom-
mend surgical closure of the patent ductus at the time of
diagnosis in adults except when there is a right to left shunt.
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